Depreciation in USD of AbCellera Biologics Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AbCellera Biologics Inc. quarterly/annual Depreciation history and growth rate from 2019 to Q3 2025.
  • AbCellera Biologics Inc. Depreciation for the quarter ending September 30, 2025 was $4.3M, a 13.2% increase year-over-year.
  • AbCellera Biologics Inc. Depreciation for the twelve months ending September 30, 2025 was $15.4M, a 8.73% increase year-over-year.
  • AbCellera Biologics Inc. annual Depreciation for 2024 was $12.5M, a 1.73% decline from 2023.
  • AbCellera Biologics Inc. annual Depreciation for 2023 was $12.8M, a 42.5% increase from 2022.
  • AbCellera Biologics Inc. annual Depreciation for 2022 was $8.95M, a 103% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

AbCellera Biologics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $15.4M $4.3M +$500K +13.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $14.9M $4.5M +$1.1M +32.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $13.8M $4.41M +$1.25M +39.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $12.5M $2.18M -$1.62M -42.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $14.2M $3.8M +$700K +22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $13.5M $3.4M +$400K +13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $13.1M $3.16M +$297K +10.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $12.8M $3.8M +$1.04M +37.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $11.7M $3.1M +$600K +24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $11.1M $3M +$700K +30.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $10.4M $2.86M +$1.47M +105% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $8.95M $2.76M +$1.5M +119% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $7.45M $2.5M +$1.3M +108% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.15M $2.3M +$1.2M +109% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $4.95M $1.39M +$551K +65.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $4.4M $1.26M +$461K +57.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $3.94M $1.2M +$1.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.74M $1.1M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.74M $840K +$425K +102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $2.32M $802K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $415K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14

AbCellera Biologics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.5M -$221K -1.73% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $12.8M +$3.81M +42.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $8.95M +$4.55M +103% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $4.4M +$2.09M +90% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $2.32M +$713K +44.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1.6M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.